Sara Feola

Sara Feola is a Senior Scientist in Immuno-oncology at Orion Corporation since February 2024, with previous experience as a Postdoctoral Researcher at the University of Helsinki from January 2018 to February 2024, focusing on Immunology, Virology, and Cancer Research, particularly in identifying tumor antigens and developing cancer vaccines. Prior to this, Sara completed a PhD at CEINGE Official Profile - Biotecnologie Avanzate Franco Salvatore, where work involved optimizing the PeptiCRAd technology. Early career stages included a traineeship at Consiglio Nazionale delle Ricerche, screening novel kinase inhibitors in thyroid carcinoma, and another traineeship at Dipartimento di Biologia e Patologia cellulare e molecolare L. Califano, where isolation and characterization of miRNA were performed. Education includes a PhD in Biotechnology and previous degrees in Medical Biotechnology and Biotechnology from Università degli Studi di Napoli Federico II.